Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Food Beverages & Tobacco | Small Cap
Health Score : 4.76Nath Bio-Genes demonstrates a mixed financial performance. Its solvency position is strong, indicating a stable financial structure. Growth metrics are promising, driven by operating profit and asset expansion. However, liquidity is a concern, with very low ratios suggesting potential difficulties in meeting short-term obligations. Financial ratios are also weak, reflecting low earnings and book value per share, although capital expenditure management is effective. Profitability is varied, with a strong return on capital employed contrasting with low margins and returns on equity and assets. While the company shows potential for growth and maintains a solid equity base, addressing liquidity and profitability challenges is crucial for sustained financial health. The company's reliance on specific operational efficiencies and asset growth highlights the need for diversified strategies to ensure long-term stability and competitiveness in the FMCG sector.
Health Score : 4.76Nath Bio-Genes demonstrates a mixed financial performance. Its solvency position is strong, indicating a stable financial structure. Growth metrics are promising, driven by operating profit and asset expansion. However, liquidity is a concern, with very low ratios suggesting potential difficulties in meeting short-term obligations. Financial ratios are also weak, reflecting low earnings and book value per share, although capital expenditure management is effective. Profitability is varied, with a strong return on capital employed contrasting with low margins and returns on equity and assets. While the company shows potential for growth and maintains a solid equity base, addressing liquidity and profitability challenges is crucial for sustained financial health. The company's reliance on specific operational efficiencies and asset growth highlights the need for diversified strategies to ensure long-term stability and competitiveness in the FMCG sector.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
6.51
Industry Median
16.68
Small Cap Median
16.68
P/E RATIO
6.95
P/B RATIO
0.43
Industry Median
2.01
Small Cap Median
2.01
P/S RATIO
0.67
Industry Median
1.30
Small Cap Median
1.30
Others
PEG RATIO
0.00
EV/EBITDA RATIO
3.63
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹152.3 as on Sep 1, 2026.
Growth Score : 4.00The company's growth metrics present a mixed picture. While operating profit and asset growth show positive momentum, revenue and net income growth are stagnant, and earnings per share growth is negative. This suggests operational improvements and asset expansion have not yet translated into overall revenue gains. Addressing revenue generation and EPS decline is crucial for sustainable growth. On the positive side, asset growth indicates potential for future expansion and increased market presence.
Revenue Growth RatePoorOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue Growth Rate | 1.74 | 5.98 | 8.06 | 66.04 |
| Operating Profit Growth Rate | 32.43 | 2.04 | 2 | 1.96 |
| Earnings Per Share (EPS) Growth | 151.97 | 13.13 | -2.59 | 7.88 |
| Asset Growth Rate | 7.31 | 10.97 | 16.59 | 6.92 |
| Net Income Growth Rate | 152.24 | 14.29 | -2.5 | 7.69 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jeyyam Global Foods Ltd | 8.14 | 7.84 | Neutral | 30.00 | 2.89 | 14.00 |
| 2 | Sheetal Universal Ltd | 7.88 | 33.73 | Neutral | 21.00 | 10.05 | 12.00 |
| 3 | Upsurge Seeds of Agriculture Ltd | 7.34 | 14.01 | Neutral | 14.00 | 7.42 | 7.00 |
| 4 | Shreeoswal Seeds & Chemicals Ltd | 6.94 | 33.38 | Overvalued | 15.00 | 0.32 | 7.00 |
| 5 | Sukhjit Starch & Chemicals Ltd | 6.56 | 18.38 | Neutral | 83.00 | 8.35 | 27.00 |
| 6 | Indo US Bio-Tech Ltd | 5.37 | 28.55 | Highly Overvalued | 6.79 | 6.55 | 5.06 |
| 7 | Nath Bio-Genes (India) Ltd | 4.76 | 6.95 | Neutral | 52.00 | 23.38 | 42.00 |
| 8 | TBI Corn Ltd | 4.72 | 6.75 | Neutral | 35.00 | 10.11 | 19.00 |
| 9 | KCK Industries Ltd | 4.67 | 211.43 | Neutral | 0.02 | 0.07 | 0.42 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Concall Report⬤11th May 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤14th Nov 25
Q2 & H1 FY26 Earnings Conference Call
NEUTRAL SENTIMENT
No Stock News Available at This Moment.
Nath Bio-Genes (India) Ltd is a prominent Indian agricultural biotechnology company focused on research, development, production, and marketing of high-quality hybrid seeds. It offers a diverse portfolio of seeds for various crops, aiming to enhance agricultural productivity and farmer profitability across India.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Nath Bio-Genes (India) Ltd's P/E ratio (TTM) is 6.51, compared to the industry median of 16.68 and large cap median of 16.68.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Nath Bio-Genes (India) Ltd's P/B ratio is 0.43, compared to the industry median of 2.01 and large cap median of 2.01.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Nath Bio-Genes (India) Ltd's P/S ratio is 0.67, compared to the industry median of 1.30 and large cap median of 1.30.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Nath Bio-Genes (India) Ltd's PEG ratio is 0.63.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Nath Bio-Genes (India) Ltd's EV/EBITDA ratio is 3.63.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Nath Bio-Genes (India) Ltd's ROE is 6.18%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Nath Bio-Genes (India) Ltd's ROA is 4.74%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Nath Bio-Genes (India) Ltd's ROCE is 7%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Nath Bio-Genes (India) Ltd's operating margin is 11.69%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Nath Bio-Genes (India) Ltd's net margin is 9.44%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Nath Bio-Genes (India) Ltd's current ratio is 2.11.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Nath Bio-Genes (India) Ltd's debt-to-equity ratio is 0.02.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Nath Bio-Genes (India) Ltd's interest coverage ratio is 3.88.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Nath Bio-Genes (India) Ltd's DPS is ₹1.97.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Nath Bio-Genes (India) Ltd's EPS is 7.88.
(Source line: "Ratios as of 23 Oct 2026, based on last traded price of ₹152.30. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1993
Headquarters: Aurangabad, Maharashtra
Core Offerings: Hybrid Seeds (Cotton, Maize, Paddy), Vegetable Seeds, Research & Development, Seed Processing & Marketing
Stock Listing: NSE (NATHBIOGEN), BSE (537291)
Promoter: Satish Kesorimal Kagliwal / Nath Group
1993: Incorporated as Nath Bio-Genes (India) Limited. 2000s: Focused on expanding its research and development capabilities and diversifying its hybrid seed portfolio. 2008: The company was listed on the National Stock Exchange (NSE) of India. Present: Continues to be a key player in the Indian seed industry, developing climate-resilient and high-yielding seed varieties for various crops.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Seeds | Almost 100% | Integrated into overall company financials |
Hybrid Seeds: Develops, produces, and markets high-yielding hybrid seeds for major field crops like Cotton, Maize, Paddy, Bajra, and Jowar, offering genetic solutions to improve agricultural output and farmer income.
Vegetable Seeds: Engages in the research, development, and distribution of a wide range of vegetable seeds, catering to diverse farming needs and contributing to food security.
Research & Development: Operates modern R&D facilities focused on crop breeding, genetic engineering, and biotechnology to innovate new seed varieties with improved traits like disease resistance, drought tolerance, and enhanced yield.
Seed Processing & Marketing: Manages robust seed processing infrastructure and an extensive marketing and distribution network across India to ensure quality seed delivery and widespread accessibility to farmers.
Mr. Satish Kesorimal Kagliwal (Chairman & Managing Director): A seasoned professional with extensive experience in the agricultural and seed industry, he provides strategic direction and leadership to the company's growth initiatives.
No major subsidiaries reported.
Rights Issue: 2021 (1:4 at ₹150 per share) Bonus Issue: 2017 (1:1 ratio)
The Nath Bio-Genes (India) Ltd share price today is ₹152.30 on NSE (NATHBIOGEN), as of 23 Oct 2026.
As of 23 Oct 2026, Nath Bio-Genes (India) Ltd share price is ₹152.30, with previous close ₹152.30. Today's range is ₹152.30 to ₹152.30. The 52-week range is ₹126.15 to ₹204.
As of today, Nath Bio-Genes (India) Ltd's market cap is ₹298.51 crore (Small Cap).
Nath Bio-Genes (India) Ltd's current P/E ratio is 6.51, compared to the FOOD BEVERAGES & TOBACCO sector average of 50.
Nath Bio-Genes (India) Ltd's current P/B ratio is 0.43.
Nath Bio-Genes (India) Ltd's current dividend yield is 1.29%. Last dividend of ₹0.50 per share was declared on 18-Aug-2023.
Nath Bio-Genes (India) Ltd's EPS (TTM) is ₹7.88.
Nath Bio-Genes (India) Ltd is a prominent Indian agricultural biotechnology company focused on research, development, production, and marketing of high-quality hybrid seeds. It offers a diverse portfolio of seeds for various crops, aiming to enhance agricultural productivity and farmer profitability across India.
Nath Bio-Genes (India) Ltd is promoted by Satish Kesorimal Kagliwal / Nath Group, holding 45.6% as of 23 Oct 2026.
Nath Bio-Genes (India) Ltd is listed on NSE (NATHBIOGEN) and BSE (537291). Its next quarterly results are expected on August 2024 (for Q1 FY25).
Cash Earnings Per Share (Cash EPS)